As for cell–matrix interactions, CD44 appears as a possible candidate since it is expressed by neoplastic pTECs preferentially in 3D cultures (Supplementary Figure 4) as well as in aggressive TETs in vivo (58) and—together with WNT4—is a marker of cancer stem cells (59–61). The gene discussed is CD44; the disease is cancer.